The DoD FY24 Toxic Exposures Research Program (TERP) Clinical Trial Award (CTA), managed by USAMRAA, supports clinical trials aimed at advancing prevention, treatment, or management of conditions related to toxic exposures in military settings. This award is intended for trials that address specific FY24 TERP Program Goals and fall within the designated TERP Topic Areas, ensuring that the research has a direct impact on issues stemming from military toxic exposures.

This opportunity expects to fund three awards with an estimated total program funding of $10.4 million. There are no restrictions on applicant eligibility, and the award does not require cost-sharing or matching funds. Applications are due by November 12, 2024, and must adhere to the guidelines for addressing TERP objectives. For further guidance, applicants can contact the CDMRP Help Desk.